Mallinckrodt appoints Christiana Stamoulis as President and CFO effective Sept 22, 2025

Keenova Therapeutics plc

Christiana Stamoulis, former Incyte CFO, becomes Mallinckrodt President & CFO effective Sept 22, 2025; prior CFO Bryan Reasons departs with severance.
Base salary set at $875,000; guaranteed FY2025 cash bonus of $700,000; annual target bonus of 80% of base salary thereafter.
Equity inducement award of $8.4M in RSUs vesting over 3 years; cash inducement award of $1M paid in two installments on July 1, 2026 and 2027.
Annual LTI grants minimum $5M per year commencing FY2026; additional $2M top-up grant in FY2026.
Severance: 1.5x base salary plus target bonus in installments; full vesting of inducement and top-up awards on termination without cause or for good reason.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.